News
6d
Zacks Investment Research on MSNRXRX Doses First Patient in Early-Stage B-Cell Lymphomas StudyRecursion Pharmaceuticals RXRX announced that it has dosed the first patient in its early-stage study of investigational ...
SGN-CD19A demonstrated anti-tumor activity across a panel of cell lines derived from multiple B-cell lymphoma and leukemia ... that define the 'ideal' ADC and mechanisms of ADC resistance require ...
While the exact mechanism still needs to be elucidated ... How Could HIV-infected Macrophages Contribute to B-cell Lymphomas? HIV-infected macrophages may contribute to lymphomagenesis through ...
Hosted on MSN3mon
Researchers reveal risks of tisa-cel therapy for relapsed or refractory B-cell lymphomasDr. Hosoya says, "Although a few case reports of laryngeal edema with tisa-cel treatment for B-cell lymphoma have appeared, the mechanism of this phenomenon is still unknown and no established ...
B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...
Diffuse large B-cell lymphoma and treatment advances for diffuse ... the signal causes the B cell to die 3. These mechanisms are shown in more detail in Figure 1. Rituximab in combination with ...
During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...
DelveInsight’s, “Non-Hodgkin Lymphoma Pipeline Insight ... address adaptive immune resistance mechanisms to enhance anticancer activity against B-cell malignancies. The drug is being evaluated ...
New imaging reveals a built-in safeguard that allows B cell ... best B cells while still improving their ability to fight infections. These principles, which shed light on precise mechanisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results